A Phase I/II Clinical Trial of LBL-033 in the Treatment of Advanced Malignant Tumors

Clinical trial NCT05779163 · COMPLETED

Trial details

NCT number: NCT05779163
Sponsor: Nanjing Leads Biolabs Co.,Ltd
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Advanced Malignant Tumors

Start date: 2023-04-14
Primary completion: 2025-04-03
Enrollment: 26

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.